DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells

Journal of Biological Chemistry

Volumn 290, Issue 31, 2015, Pages 19173-19183

  Tian, Hong Pan ^a   Lun, Shu Min ^a   Huang, Huan Jing ^a   He, Rui ^a   Kong, Peng Zhou ^a   Wang, Qing Shan ^a   Li, Xiao Qing ^a   Feng, Yu Mei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; DISEASES; METHYLATION;

BREAST CANCER CELLS; COMBINED EFFECT; DNA METHYLATION; HYPERMETHYLATION; PROMOTER METHYLATION; REGULATION OF TRANSCRIPTION; REGULATORY MECHANISM; TRANSCRIPTIONAL REGULATION;

TRANSCRIPTION;

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FORKHEAD BOX F2; FORKHEAD TRANSCRIPTION FACTOR; GENOMIC DNA; MESSENGER RNA; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; FOXF2 PROTEIN, HUMAN; SP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SP1;

ARTICLE; BASAL LIKE BREAST CANCER CELL; BINDING SITE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FOXF2 GENE; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MDA MB 453 CELL LINE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEFICIENCY; PROTEIN DNA BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; BASAL CELL CARCINOMA; BREAST TUMOR; CELL MOTION; DISEASE FREE SURVIVAL; FEMALE; GENETIC EPIGENESIS; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MOLECULAR GENETICS; MORTALITY; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

BASE SEQUENCE; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; CPG ISLANDS; DISEASE-FREE SURVIVAL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MCF-7 CELLS; MOLECULAR SEQUENCE DATA; NEOPLASMS, BASAL CELL; PROMOTER REGIONS, GENETIC; SP1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84940567256     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.636126     Document Type: Article

References (33)

1. Wang, T., Tamakoshi, T., Uezato, T., Shu, F., Kanzaki-Kato, N., Fu, Y., Koseki, H., Yoshida, N., Sugiyama, T., and Miura, N. (2003) Forkhead transcription factor Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate. Dev. Biol. 259, 83-94
2. Ormestad, M., Astorga, J., Landgren, H., Wang, T., Johansson, B. R., Miura, N., and Carlsson, P. (2006) Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 133, 833-843
3. Aitola, M., Carlsson, P., Mahlapuu, M., Enerbäck, S., and Pelto-Huikko, M. (2000) Forkhead transcription factor FoxF2 is expressed in mesodermal tissues involved in epithelio-mesenchymal interactions. Dev. Dyn. 218, 136-149
4. Van Der Heul-Nieuwenhuijsen, L., Hendriksen, P. J., Van Der Kwast, T. H., and Jenster, G. (2006) Gene expression profiling of the human prostate zones. BJU Int. 98, 886-897
5. Hirata, H., Ueno, K., Shahryari, V., Deng, G., Tanaka, Y., Tabatabai, Z. L., Hinoda, Y., and Dahiya, R. (2013) MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS ONE 8, e55502
6. Shi, W., Gerster, K., Alajez, N. M., Tsang, J., Waldron, L., Pintilie, M., Hui, A. B., Sykes, J., P'ng, C., Miller, N., McCready, D., Fyles, A., and Liu, F. F. (2011) MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res. 71, 2926-2937
7. Kong, P.-Z., Yang, F., Li, L., Li, X.-Q., and Feng, Y.-M. (2013) Decreased FOXF2mRNAexpression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor. PLoS ONE 8, e61591
8. Wang, Q.-S., Kong, P.-Z., Li, X.-Q., Yang, F., and Feng, Y.-M. (2015) FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer. Breast Cancer Res. 17, 30
9. Jones, P. A. (2012) Functions ofDNAmethylation: Islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484-492
10. Medvedeva, Y. A., Khamis, A. M., Kulakovskiy, I. V., Ba-Alawi, W., Bhuyan, M. S., Kawaji, H., Lassmann, T., Harbers, M., Forrest, A. R., and Bajic, V. B. (2014) Effects of cytosine methylation on transcription factor binding sites. BMC Genomics 15, 119
11. Valastyan, S., and Weinberg, R. A. (2011) Tumor metastasis: Molecular insights and evolving paradigms. Cell 147, 275-292
12. Wu, C. Y., Tsai, Y. P., Wu, M. Z., Teng, S. C., and Wu, K. J. (2012) Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet. 28, 454-463
13. Huang, Y., and Rao, A. (2014) Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet. 30, 464-474
14. Dunwell, T., Hesson, L., Rauch, T. A., Wang, L., Clark, R. E., Dallol, A., Gentle, D., Catchpoole, D., Maher, E. R., Pfeifer, G. P., and Latif, F. (2010) A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol. Cancer 9, 44
15. Yu, Y., Xiao, C. H., Tan, L. D., Wang, Q.-S., Li, X.-Q., and Feng, Y.-M. (2014) Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF - signalling. Br. J. Cancer 110, 724-732
16. Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., Vidaurre, T., Holmes, F., Souchon, E., Wang, H., Martin, M., Cotrina, J., Gomez, H., Hubbard, R., Chacón, J. I., Ferrer-Lozano, J., Dyer, R., Buxton, M., Gong, Y., Wu, Y., Ibrahim, N., Andreopoulou, E., Ueno, N. T., Hunt, K., Yang, W., Nazario, A., DeMichele, A., O'Shaughnessy, J., Hortobagyi, G. N., and Symmans, W. F. (2011) A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305, 1873-1881
17. Hsu, T. I., Wang, M. C., Chen, S. Y., Yeh, Y. M., Su, W. C., Chang, W. C., and Hung, J. J. (2012) Sp1 expression regulates lung tumor progression. Oncogene 31, 3973-3988
18. Black, A. R., Black, J. D., and Azizkhan-Clifford, J. (2001) Sp1 and krüppellike factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188, 143-160
19. Van Der Heul-Nieuwenhuijsen, L., Dits, N. F., and Jenster, G. (2009) Gene expression of forkhead transcription factors in the normal and diseased human prostate. BJU Int. 103, 1574-1580
20. Turek-Plewa, J., and Jagodzi?ski, P. P. (2005) The role of mammalianDNA methyltransferases in the regulation of gene expression. Cell. Mol. Biol. Lett. 10, 631-647
21. Denis, H., Ndlovu, M. N., and Fuks, F. (2011) Regulation of mammalian DNA methyltransferases: A route to new mechanisms. EMBO Rep. 12, 647-656
22. Chang, H. C., Cho, C. Y., and Hung, W. C. (2006) Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res. 66, 8413-8420
23. Narayan, V. A., Kriwacki, R. W., and Caradonna, J. P. (1997) Structures of zinc finger domains from transcription factor Sp1. Insights into sequencespecific protein-DNA recognition. J. Biol. Chem. 272, 7801-7809
24. Reamon-Buettner, S. M., and Borlak, J. (2008) Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors. Cancer Res. 68, 7587-7596
25. Guo, D., Wu, B., Yan, J., Li, X., Sun, H., and Zhou, D. (2012)Apossible gene silencing mechanism: Hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells. Biochem. Biophys. Res. Commun. 428, 80-85
26. Shen, L., Qu, X., Ma, Y., Zheng, J., Chu, D., Liu, B., Li, X., Wang, M., Xu, C., Liu, N., Yao, L., and Zhang, J. (2014) Tumor suppressor NDRG2 tips the balance of oncogenic TGF - via EMT inhibition in colorectal cancer. Oncogenesis 3, e86
27. Jungert, K., Buck, A., Von Wichert, G., Adler, G., König, A., Buchholz, M., Gress, T. M., and Ellenrieder, V. (2007) Sp1 is required for transforming growth factor -induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res. 67, 1563-1570
28. Lu, S., and Archer, M. C. (2010) Sp1 coordinately regulates De novo lipogenesis and proliferation in cancer cells. Int. J. Cancer 126, 416-425
29. Verras, M., Lee, J., Xue, H., Li, T. H., Wang, Y., and Sun, Z. (2007) The androgen receptor negatively regulates the expression of c-Met: Implications for a novel mechanism of prostate cancer progression. Cancer Res. 67, 967-975
30. Yue, L., Li, L., Liu, F., Hu, N., Zhang, W., Bai, X., Li, Y., Zhang, Y., Fu, L., Zhang, X., and Ye, L. (2013) The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells. Carcinogenesis 34, 927-935
31. Kolesnikoff, N., Attema, J. L., Roslan, S., Bert, A. G., Schwarz, Q. P., Gregory, P. A., and Goodall, G. J. (2014) Specificity Protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family. Implications for epithelial-mesenchymal transition. J. Biol. Chem. 289, 11194-11205
32. Sun, L., Li, H., Chen, J., Dehennaut, V., Zhao, Y., Yang, Y., Iwasaki, Y., Kahn-Perles, B., Leprince, D., Chen, Q., Shen, A., and Xu, Y. (2013) A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. J. Natl. Cancer Inst. 105, 887-898
33. Liu, Y. N., Lee, W. W., Wang, C. Y., Chao, T. H., Chen, Y., and Chen, J. H. (2005) Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 24, 8277-8290